Advanced prostate cancer indicates a significant challenge to healthcare professionals and patients alike. Traditional treatment modalities often prove limited effectiveness in managing the disease's progression. In recent years, however, a novel therapeutic agent has emerged as a promising option for patients with advanced prostate cancer: abirate